Clinical Trials Logo

Clinical Trial Summary

The main objective of this study is to find out whether young MSM (men who have sex with men) believe it is important for their GP to be informed of their sexual orientation, in order to improve their clinical, especially with HPV vaccination. The secondary objective is to analyze the state of knowledge about the HPV vaccine and the value of HPV vaccine in this target population.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05078554
Study type Observational
Source University Hospital, Strasbourg, France
Contact
Status Completed
Phase
Start date May 27, 2021
Completion date January 27, 2022

See also
  Status Clinical Trial Phase
Completed NCT03584308 - Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal Phase 2
Completed NCT04459221 - Study of the Impact of a School Program Combining - Promotion of HPV Vaccination and HPV Vaccine Offer in Middle School - on Adherence to HPV Vaccination in Middle School Students Phase 4
Not yet recruiting NCT06416150 - Reducing Urban Cervical Cancer Disparities N/A
Completed NCT02114385 - A Study to Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men (V503-020) Phase 3
Recruiting NCT05916911 - Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR) Phase 4
Completed NCT01030562 - Immunogenicity of Off-Schedule Dosing of HPV Vaccine